These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20634301)

  • 21. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of dual PPAR
    Ericsson A; Tonelius P; Lal M; Sabirsh A; Böttcher G; William-Olsson L; Strömstedt M; Johansson C; Hyberg G; Tapani S; Jönsson-Rylander AC; Unwin R
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.
    Waasdorp M; Florquin S; Duitman J; Spek CA
    FASEB J; 2019 Oct; 33(10):10966-10972. PubMed ID: 31287960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in animal models of diabetic nephropathy.
    Betz B; Conway BR
    Nephron Exp Nephrol; 2014; 126(4):191-5. PubMed ID: 25034792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
    Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
    J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of human diabetic nephropathy.
    Najafian B; Alpers CE; Fogo AB
    Contrib Nephrol; 2011; 170():36-47. PubMed ID: 21659756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy.
    Lavoz C; Rodrigues-Diez RR; Plaza A; Carpio D; Egido J; Ruiz-Ortega M; Mezzano S
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31973092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.
    Opazo-Ríos L; Tejera-Muñoz A; Soto Catalan M; Marchant V; Lavoz C; Mas Fontao S; Moreno JA; Fierro Fernandez M; Ramos R; Suarez-Alvarez B; López-Larrea C; Ruiz-Ortega M; Egido J; Rodrigues-Díez RR
    Front Pharmacol; 2022; 13():778776. PubMed ID: 35370692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis.
    Bornfeldt KE; Kramer F; Batorsky A; Choi J; Hudkins KL; Tontonoz P; Alpers CE; Kanter JE
    Am J Pathol; 2018 Feb; 188(2):343-352. PubMed ID: 29154962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.
    Opazo-Ríos L; Soto-Catalán M; Lázaro I; Sala-Vila A; Jiménez-Castilla L; Orejudo M; Moreno JA; Egido J; Mas-Fontao S
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.
    Opazo-Ríos L; Plaza A; Sánchez Matus Y; Bernal S; Lopez-Sanz L; Jimenez-Castilla L; Carpio D; Droguett A; Mezzano S; Egido J; Gomez-Guerrero C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy.
    Andeen NK; Nguyen TQ; Steegh F; Hudkins KL; Najafian B; Alpers CE
    Kidney Int; 2015 Nov; 88(5):1099-107. PubMed ID: 26376129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
    Takahashi T; Harris RC
    J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.
    Takahashi N; Yoshida H; Kimura H; Kamiyama K; Kurose T; Sugimoto H; Imura T; Yokoi S; Mikami D; Kasuno K; Kurosawa H; Hirayama Y; Naiki H; Hara M; Iwano M
    Nephrol Dial Transplant; 2020 Oct; 35(10):1678-1688. PubMed ID: 32596728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice.
    de Groot T; Damen L; Kosse L; Alsady M; Doty R; Baumgarten R; Sheehan S; van der Vlag J; Korstanje R; Deen PMT
    PLoS One; 2017; 12(12):e0189485. PubMed ID: 29244860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.